Investments | NOTE 2. INVESTMENTS Securities Available-for-Sale The amortized cost, gross unrealized gains and losses, and fair value of the Company’s debt securities available-for-sale are as follows for the periods presented: September 30, 2023 Cost or Adjusted / Gross Unrealized Gross Unrealized Fair Value Debt Securities Available-for-sale (In thousands) U.S. government and agency securities (1) $ 174,962 $ 5 $ 2,377 $ 172,590 States, municipalities and political subdivisions 94,079 — 12,099 81,980 Special revenue 256,159 — 33,054 223,104 Industrial and miscellaneous 191,247 7 17,409 173,845 Total $ 716,447 $ 12 $ 64,939 $ 651,520 (1) Includes securities at September 30, 2023 with a carrying amount of $ 25.3 million that were pledged as collateral for the advance agreement entered into with a financial institution in 2018. The Company is permitted to withdraw or exchange any portion of the pledged collateral over the minimum requirement at any time. December 31, 2022 Cost or Adjusted / Gross Unrealized Gross Unrealized Fair Value Debt Securities Available-for-sale (In thousands) U.S. government and agency securities (1) $ 121,811 $ 24 $ 4,093 $ 117,742 States, municipalities and political subdivisions 104,361 — 12,734 91,627 Special revenue 284,946 1 34,817 250,130 Industrial and miscellaneous 194,430 90 18,447 176,073 Total $ 705,548 $ 115 $ 70,091 $ 635,572 (1) Includes securities at December 31, 2022 with a carrying amount of $ 24.3 million that were pledged as collateral for the advance agreement entered into with a financial institution in 2018. The Company is permitted to withdraw or exchange any portion of the pledged collateral over the minimum requirement at any time. Net Realized and Unrealized Losses and Impairments The following tables present net realized losses on the Company’s debt securities available-for-sale for the three and nine months ended September 30, 2023 and 2022, respectively : 2023 2022 Three Months Ended September 30, Gains Fair Value at Sale Gains Fair Value at Sale (In thousands) Debt Securities Available-for-Sale Total realized gains $ 2 $ 1,498 $ — $ 50 Total realized losses ( 381 ) 40,705 ( 3 ) 110 Net realized losses $ ( 379 ) $ 42,202 $ ( 3 ) $ 160 2023 2022 Nine Months Ended September 30, Gains Fair Value at Sale Gains Fair Value at Sale (In thousands) Debt Securities Available-for-Sale Total realized gains $ 1 $ 1,900 $ 32 $ 2,451 Total realized losses ( 391 ) 41,137 ( 153 ) 6,206 Net realized losses $ ( 390 ) $ 43,037 $ ( 121 ) $ 8,657 The following table presents the reconciliation of net realized losses and impairments of the Company’s investments reported for the three and nine months ended September 30, 2023 and 2022, respectively: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 (In thousands) Gross realized gains on sales of available-for-sale securities $ 2 $ — $ 1 $ 32 Impairments on other investments — — ( 1,559 ) — Realized losses on sales of available-for-sale securities ( 381 ) ( 3 ) ( 391 ) ( 153 ) Gross realized gains on sale of other investments (1) — — 1,900 — Net realized losses and impairments $ ( 379 ) $ ( 3 ) $ ( 49 ) $ ( 121 ) (1) During the first quarter, the Company sold its investment in an Insurtech company for $ 4.0 million, resulting in a $ 1.9 million realized gain on the investment. The table below summarizes the Company’s debt securities at September 30, 2023 by contractual maturity periods. Actual results may differ as issuers may have the right to call or prepay obligations, with or without penalties, prior to the contractual maturity of those obligations. At September 30, 2023 Cost or Amortized Cost Percent of Total Fair Value Percent of Total Maturity dates: (In thousands) (In thousands) Due in one year or less $ 177,224 24.7 % $ 175,446 26.9 % Due after one year through five years 356,122 49.7 % 325,531 50.0 % Due after five years through ten years 148,815 20.8 % 121,684 18.7 % Due after ten years 34,286 4.8 % 28,859 4.4 % Total $ 716,447 100.0 % $ 651,520 100.0 % Net Investment Income The following table summarizes the Company’s net investment income by major investment category for the three and nine months ended September 30, 2023 and 2022, respectively: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 (In thousands) Debt securities $ 4,685 $ 2,992 $ 12,723 $ 7,695 Equity securities 79 — 170 — Cash and cash equivalents 1,746 273 6,195 433 Other investments 687 135 1,525 447 Net investment income 7,197 3,400 20,613 8,575 Less: Investment expenses 330 513 1,565 1,525 Net investment income, less investment expenses $ 6,867 $ 2,887 $ 19,048 $ 7,050 The following tables present, for all debt securities available-for-sale in an unrealized loss position (including securities pledged) and for which no credit loss allowance has been established to date, the aggregate fair value and gross unrealized loss by length of time the security has continuously been in an unrealized loss position at September 30, 2023 and December 31, 2022, respectively (in thousands): Less Than Twelve Months Twelve Months or More September 30, 2023 Number of Gross Fair Value Number of Gross Fair Value Debt Securities Available-for-sale U.S. government and agency securities 24 $ 141 $ 67,724 58 $ 2,236 $ 63,678 States, municipalities and political subdivisions 2 32 2,261 109 12,067 77,265 Special revenue 26 184 11,773 427 32,870 208,881 Industrial and miscellaneous 56 523 34,925 211 16,886 133,162 Total fixed maturity securities 108 $ 880 $ 116,683 805 $ 64,059 $ 482,986 Less Than Twelve Months Twelve Months or More December 31, 2022 Number of Gross Fair Value Number of Gross Fair Value Debt Securities Available-for-sale U.S. government and agency securities 61 $ 2,040 $ 56,389 36 $ 2,053 $ 56,389 States, municipalities and political 28 1,967 17,730 95 10,767 68,852 Special revenue 273 5,832 57,881 259 28,985 167,384 Industrial and miscellaneous 95 1,535 32,387 197 16,912 134,462 Total fixed maturity securities 457 $ 11,374 $ 164,386 587 $ 58,717 $ 427,087 The Company’s unrealized losses on corporate bonds have not been recognized because the bonds are of a high credit quality with investment grade ratings. The average rating was an A+ for the nine months ended September 30, 2023. The Company does not intend to sell and it is unlikely the Company will be required to sell the securities prior to their anticipated recovery. The debt issuers continue to make timely principal and interest payments on the bonds. After taking into account these and other factors previously described, the Company believes these unrealized losses generally were caused by an increase in market interest rates since the time the securities were purchased and not as a result of credit losses. No credit loss allowan ce was recorded for the nine months ended September 30, 2023 or for the year ended December 31, 2022. Quarterly, the Company considers whether it intends to sell an available-for-sale security or if it is more likely than not that it will be required to sell the security before recovery of its amortized costs. In these instances, a decline in fair value is recognized in net income based on the fair value of the security at the time of assessment, resulting in a new cost basis for the security. Other Investments Non-Consolidating Variable Interest Entities (“VIEs”) The Company makes passive investments in limited partnerships (“LPs”), which are accounted for using the equity method, with income reported in earnings. The Company also holds a passive investment in a Real Estate Investment Trust (“REIT”), which is accounted for using the measurement alternative method, and reported at cost less impairment (if any), plus or minus changes from observable price changes. During the nine months ended September 30, 2023, the Company recorded a $ 1.6 million impairment on certain non-consolidated VIEs. At December 31, 2022, the Company held an equity investment in an Insurtech company, which was sold during the three months ended March 31, 2023 at a gain. The following table summarizes the carrying value and maximum loss exposure of the Company’s non-consolidated VIEs at September 30, 2023 and December 31, 2022, respectively (in thousands): As of September 30, 2023 As of December 31, 2022 Carrying Value Maximum Loss Exposure Carrying Value Maximum Loss Exposure Investments in non-consolidated VIEs - Equity method $ 1,821 $ 1,821 $ 3,517 $ 3,517 Investments in non-consolidated VIEs - Amortized cost $ 8,490 $ 8,490 $ 8,490 $ 8,490 Investments in non-consolidated VIEs - Measurement alternative $ 1,434 $ 1,434 $ 4,477 $ 4,477 Total non-consolidated VIEs $ 11,745 $ 11,745 $ 16,484 $ 16,484 No agreements exist requiring the Company to provide additional funding to any of the non-consolidated VIEs in excess of the Company’s initial investment. |